Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06195163
PHASE4

TRAP Study: Testosterone for Androgen Receptor Polymorphism

Sponsor: Instituto Bernabeu

View on ClinicalTrials.gov

Summary

To determine whether pretreatment with transdermal testosterone increases the number of cumulus-oocyte complexes (COCs) obtained after ovarian stimulation by more than 1.5 in patients with low ovarian reserve and androgen receptor polymorphism undergoing intracytoplasmic sperm injection (ICSI).

Official title: Transdermal Testosterone Pretreatment in Poor Responders With Androgen Receptor Polymorphism Undergoing ICSI: A Randomized Clinical Investigation.

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2025-09-30

Completion Date

2026-12-31

Last Updated

2025-05-09

Healthy Volunteers

Yes

Interventions

DRUG

Transdermal Gel in Sachet Dosage Form

Transdermal testosterone gel application prior to ovarian stimulation in the study group.

DRUG

No pretreatment

No pretreatment prior to the ovarian stimulation in the control group.

Locations (1)

Instituto Bernabeu

Alicante, Alicante, Spain